The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> WHO and World Trade Organization Host Closed Meetings to Tackle Vaccine Access and Prices 13/04/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) and the World Trade Organization (WTO) both are hosting key global meetings aimed at improving global access to COVID-19 vaccines and fair medicine prices this week behind closed doors. The WHO Fair Pricing Forum started on Tuesday and its stated aim is to activate “additional support for countries to achieve […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> WHO and World Trade Organization Host Closed Meetings to Tackle Vaccine Access and Prices 13/04/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) and the World Trade Organization (WTO) both are hosting key global meetings aimed at improving global access to COVID-19 vaccines and fair medicine prices this week behind closed doors. The WHO Fair Pricing Forum started on Tuesday and its stated aim is to activate “additional support for countries to achieve […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> WHO and World Trade Organization Host Closed Meetings to Tackle Vaccine Access and Prices 13/04/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) and the World Trade Organization (WTO) both are hosting key global meetings aimed at improving global access to COVID-19 vaccines and fair medicine prices this week behind closed doors. The WHO Fair Pricing Forum started on Tuesday and its stated aim is to activate “additional support for countries to achieve […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> WHO and World Trade Organization Host Closed Meetings to Tackle Vaccine Access and Prices 13/04/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) and the World Trade Organization (WTO) both are hosting key global meetings aimed at improving global access to COVID-19 vaccines and fair medicine prices this week behind closed doors. The WHO Fair Pricing Forum started on Tuesday and its stated aim is to activate “additional support for countries to achieve […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> WHO and World Trade Organization Host Closed Meetings to Tackle Vaccine Access and Prices 13/04/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) and the World Trade Organization (WTO) both are hosting key global meetings aimed at improving global access to COVID-19 vaccines and fair medicine prices this week behind closed doors. The WHO Fair Pricing Forum started on Tuesday and its stated aim is to activate “additional support for countries to achieve […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> WHO and World Trade Organization Host Closed Meetings to Tackle Vaccine Access and Prices 13/04/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) and the World Trade Organization (WTO) both are hosting key global meetings aimed at improving global access to COVID-19 vaccines and fair medicine prices this week behind closed doors. The WHO Fair Pricing Forum started on Tuesday and its stated aim is to activate “additional support for countries to achieve […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> WHO and World Trade Organization Host Closed Meetings to Tackle Vaccine Access and Prices 13/04/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) and the World Trade Organization (WTO) both are hosting key global meetings aimed at improving global access to COVID-19 vaccines and fair medicine prices this week behind closed doors. The WHO Fair Pricing Forum started on Tuesday and its stated aim is to activate “additional support for countries to achieve […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO and World Trade Organization Host Closed Meetings to Tackle Vaccine Access and Prices 13/04/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) and the World Trade Organization (WTO) both are hosting key global meetings aimed at improving global access to COVID-19 vaccines and fair medicine prices this week behind closed doors. The WHO Fair Pricing Forum started on Tuesday and its stated aim is to activate “additional support for countries to achieve […] Continue reading -> Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Plots Ambitious Vaccine Targets at Manufacturing Conference 12/04/2021 Paul Adepoju African vaccine producers supply just 1% of the continent’s needs at present – but the plan is to increase this to 60% by 2040, according to John Nkengasong, Director of the Africa Centers for Disease Control (CDC). “The vision is to ensure Africa has timely access to vaccines to protect public health security, by establishing […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts